Wealth Alliance Novo Nordisk A S Transaction History

Wealth Alliance

$902 Million
Q3 2025

A detailed history of Wealth Alliance transactions in Novo Nordisk A S stock. As of the latest transaction made, Wealth Alliance holds 5,074 shares of NVO stock, worth $245,886. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,074

Previous 15,844 67.98%

Holding current value

$245,886

Previous $1.09 Million 74.29%

% of portfolio

0.03%

Previous 0.13%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$45.38 - $71.7 $488,742 - $772,209	-10,770 Reduced 67.98%	5,074 $281,000
Q2 2025 Aug 08, 2025	SELL	$58.08 - $81.05 $19,631 - $27,394	-338 Reduced 2.09%	15,844 $1.09 Million
Q1 2025 May 05, 2025	BUY	$69.3 - $90.95 $336,312 - $441,380	4,853 Added 42.84%	16,182 $1.12 Million
Q4 2024 Feb 03, 2025	SELL	$85.0 - $120.04 $21,165 - $29,889	-249 Reduced 2.15%	11,329 $974,000
Q3 2024 Nov 04, 2024	BUY	$119.07 - $145.42 $1,786 - $2,181	15 Added 0.13%	11,578 $1.38 Million

Q2 2024 Aug 09, 2024	BUY	$122.71 - $146.91 $30,063 - $35,992	245 Added 2.16%	11,563 $1.65 Million
Q1 2024 May 10, 2024	SELL	$102.11 - $135.92 $52,892 - $70,406	-518 Reduced 4.38%	11,318 $1.45 Million
Q4 2023 Jan 30, 2024	BUY	$87.78 - $105.45 $27,475 - $33,005	313 Added 2.72%	11,836 $1.22 Million
Q3 2023 Nov 09, 2023	BUY	$90.94 - $199.54 $562,191 - $1.23 Million	6,182 Added 115.75%	11,523 $1.05 Million
Q2 2023 Aug 02, 2023	SELL	$155.98 - $172.65 $51,941 - $57,492	-333 Reduced 5.87%	5,341 $864,000
Q1 2023 May 10, 2023	SELL	$132.34 - $159.14 $67,361 - $81,002	-509 Reduced 8.23%	5,674 $902,000
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $63,170 - $83,363	616 Added 11.07%	6,183 $836,000
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $112,906 - $138,562	1,185 Added 27.04%	5,567 $555,000
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $71,751 - $84,657	-695 Reduced 13.69%	4,382 $488,000
Q1 2022 May 10, 2022	BUY	$93.1 - $112.54 $11,916 - $14,405	128 Added 2.59%	5,077 $564,000
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $1,821 - $2,224	-19 Reduced 0.38%	4,949 $554,000
Q3 2021 Nov 12, 2021	SELL	$84.42 - $106.62 $10,552 - $13,327	-125 Reduced 2.45%	4,968 $477,000
Q2 2021 Aug 16, 2021	BUY	$67.66 - $84.76 $67 - $84	1 Added 0.02%	5,093 $427,000
Q1 2021 May 18, 2021	BUY	$67.06 - $75.82 $5,029 - $5,686	75 Added 1.49%	5,092 $343,000
Q4 2020 Feb 11, 2021	SELL	$63.89 - $73.8 $21,722 - $25,092	-340 Reduced 6.35%	5,017 $350,000
Q3 2020 Nov 13, 2020	BUY	$63.69 - $70.22 $4,585 - $5,055	72 Added 1.36%	5,357 $372,000
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $37,816 - $43,889	646 Added 13.93%	5,285 $346,000
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $229,444 - $300,514	4,639 New	4,639 $279,000

Others Institutions Holding NVO

# of Institutions

1,693

Shares Held

303M

Call Options Held

25.9M

Put Options Held

43.8M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Alliance with notifications on news.

Account